Delta sleep-inducing peptide administration does not influence growth hormone and prolactin secretion in normal women.
The aim of this study was to analyze the effects of delta sleep-inducing peptide (DSIP) on growth hormone (GH) and prolactin (PRL) secretion in eight healthy women with normal cycles (aged 17-36 years). GH and PRL secretion was studied in five women after DSIP (25 micrograms/kg bw IV over 30 min), arginine chlorhydrate (0.5 g/kg bw IV over 30 min) and simultaneous DSIP plus arginine chlorhydrate administration. In three other women the circadian rhythm of GH and PRL was studied during DSIP (25 micrograms/kg bw from 2130h to 2230h) and placebo IV infusion. Serum GH and PRL levels were normal under basal conditions and no effects were noted after the infusion of DSIP. The GH and PRL circadian rhythm was not modified by DSIP administration. DSIP did not influence GH and PRL responsiveness to arginine chlorhydrate. We found that at dosages which are known to modify ECG patterns, DSIP is unable to modify spontaneous or arginine chlorhydrate-induced GH and PRL secretion.
Giusti
M
M
DISEM, Cattedra di Endocrinologia, Università di Genova, Italy.
Carraro
A
A
Porcella
E
E
Valenti
S
S
Nicora
D
D
Sessarego
P
P
Giordano
G
G
D000293:Adolescent; D000328:Adult; D001120:Arginine / Q000494:pharmacology; D003701:Delta Sleep-Inducing Peptide / Q000009:adverse effects / Q000494:pharmacology*; D004562:Electrocardiography; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007986:Luteinizing Hormone / Q000097:blood; D011388:Prolactin / Q000097:blood*
D003701:Delta Sleep-Inducing Peptide; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013006:Growth Hormone; D001120:Arginine; D006854:Hydrocortisone